RP Bio Inc. (KOSDAQ:314140)
South Korea · Delayed Price · Currency is KRW 5,980.00
-90.00 (-1.48%)
At close: Sep 11, 2026
RP Bio Market Cap
RP Bio has a market cap or net worth of 51.82 billion as of September 11, 2026. Its market cap has decreased by -9.53% in one year.
Market Cap
51.82B
Enterprise Value
51.30B
Revenue
141.42B
Ranking
n/a
PE Ratio
7.69
Stock Price
5,980.00
ChartMarket Cap Chart
Since September 29, 2022, RP Bio's market cap has decreased from 143.18B to 51.82B, a decrease of -63.80%. That is a compound annual growth rate of -22.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 51.82B | -19.19% |
| Dec 30, 2025 | 64.13B | 46.53% |
| Dec 30, 2024 | 43.77B | -41.62% |
| Dec 28, 2023 | 74.96B | -26.88% |
| Dec 29, 2022 | 102.52B | -28.40% |
| Sep 29, 2022 | 143.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharos iBio | 71.46B |
| Sinsin Pharmaceutical | 70.47B |
| Optipharm.CO.,LTD | 70.27B |
| Sinil Pharmaceutical | 68.83B |
| Hwail Pharmaceutical | 67.65B |
| BL Pharmtech | 58.47B |
| Jin Yang Pharmaceutical | 51.12B |
| Organoidsciences | 43.80B |